Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Luye Pharma Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Luye Pharma Group Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Luye Pharma Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Luye Pharma Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Luye Pharma Group Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Luye Pharma Group Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Luye Pharma Group Ltd, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Shandong Luye Pharma Acquires LY01008 and LY06006 from Shandong Boan Biological Technology for USD67 Million 12
Private Equity 13
CDH Investments, CITIC Private Equity and New Horizon Acquires Majority Stake in Luye Pharma 13
Partnerships 14
Luye Pharma Enters into Partnership with Elpis Biopharma 14
Licensing Agreements 15
Luye Pharma and Luye Supply to Enter into Agreement with Bayer 15
Abpro Enters into Licensing Agreement with Luye Pharma 16
Hanmi Pharm Enters into Licensing Agreement with Luye Pharma for Poziotinib 17
Excel BioPharma Enters into Licensing Agreement with Luye Pharma 18
Luye Pharma Group Enters Into Licensing Agreement With Dong-A Pharma For DA-1229 19
Equity Offering 20
Exicure Raises Additional USD11.2 Million in Private Placement of Shares 20
Luye Pharma Completes IPO 21
Debt Offering 23
Luye Pharma Plans to Raise up to USD302.6 Million in Public Offering of Notes 23
Acquisition 24
Luye Group May Acquire Ethypharm from Astorg Partners 24
A-Bio Pharma To Acquire 10% Stake In PrIME Biologics From NuSep For US$4.8 Million 25
Luye Pharma Group Ltd – Key Competitors 26
Luye Pharma Group Ltd – Key Employees 27
Luye Pharma Group Ltd – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 31
Financial Announcements 31
Mar 26, 2018: Luye Pharma Group: Annual Results Announcement For The Year Ended 31 December 2017 31
Aug 28, 2017: Luye Pharma Group: Announcement Of Interim Results For The Six Months Ended 30 June 2017 36
Mar 29, 2017: Luye Pharma Group: Annual Results Announcement For The Year Ended 31 December 2016 41
Clinical Trials 42
Jun 19, 2018: Luye Pharma Bolsters Its Global Analgesics Portfolio with China Class 1.1 New Compound LY03012 to Start Phase I Clinical Trials 42
Other Significant Developments 43
May 27, 2017: Investors flock to exicure s IPO – Luye Pharma s strategy of investment in novel biopharmaceuticals receives optimistic outlook 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44
Luye Pharma Group Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Luye Pharma Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Luye Pharma Group Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Luye Pharma Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Luye Pharma Group Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Luye Pharma Group Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Luye Pharma Group Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Shandong Luye Pharma Acquires LY01008 and LY06006 from Shandong Boan Biological Technology for USD67 Million 12
CDH Investments, CITIC Private Equity and New Horizon Acquires Majority Stake in Luye Pharma 13
Luye Pharma Enters into Partnership with Elpis Biopharma 14
Luye Pharma and Luye Supply to Enter into Agreement with Bayer 15
Abpro Enters into Licensing Agreement with Luye Pharma 16
Hanmi Pharm Enters into Licensing Agreement with Luye Pharma for Poziotinib 17
Excel BioPharma Enters into Licensing Agreement with Luye Pharma 18
Luye Pharma Group Enters Into Licensing Agreement With Dong-A Pharma For DA-1229 19
Exicure Raises Additional USD11.2 Million in Private Placement of Shares 20
Luye Pharma Completes IPO 21
Luye Pharma Plans to Raise up to USD302.6 Million in Public Offering of Notes 23
Luye Group May Acquire Ethypharm from Astorg Partners 24
A-Bio Pharma To Acquire 10% Stake In PrIME Biologics From NuSep For US$4.8 Million 25
Luye Pharma Group Ltd, Key Competitors 26
Luye Pharma Group Ltd, Key Employees 27
Luye Pharma Group Ltd, Other Locations 28
Luye Pharma Group Ltd, Subsidiaries 28
List of Figures
Luye Pharma Group Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Luye Pharma Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Luye Pharma Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Luye Pharma Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Luye Pharma Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Luye Pharma Group Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Luye Pharma Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Luye Pharma Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Luye Pharma Group Ltd, Medical Devices Deals, 2012 to YTD 2018 10